| Dr Daniel George Hoody, MD | |
|
1300 Anne St Nw, Bemidji, MN 56601-5103 | |
| (218) 333-5000 | |
| Not Available |
| Full Name | Dr Daniel George Hoody |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 16 Years |
| Location | 1300 Anne St Nw, Bemidji, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871766923 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 55317 (Minnesota) | Primary |
| 207R00000X | Internal Medicine | 55317 (Minnesota) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sanford Bemidji Medical Center | Bemidji, MN | Hospital |
| Hennepin County Medical Center 1 | Minneapolis, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sanford Health Of Northern Minnesota | 5597725168 | 258 |
News Archive
The Association for Molecular Pathology (AMP) is an international medical and professional association representing approximately 1,800 physicians, doctoral scientists, and medical laboratory scientists who perform laboratory testing based on knowledge derived from molecular biology, genetics, and genomics. AMP applauds US District Judge Robert Sweet's ruling in favor of the plaintiffs in the lawsuit, Association for Molecular Pathology, et al. v. U.S. Patent and Trademark Office, et al.
A French–Spanish research team has now developed a new type of carrier that can take on a particularly large "load" of medication and then release it in a controlled fashion: metal–organic frameworks with large cavities.
With a bipartisan budget deal behind it, Congress may be on the verge of solving the way it makes Medicare payments to doctors. Meanwhile, national spending on health care is growing at the slowest pace ever recorded, according to The New York Times.
Clovis Oncology, Inc., a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents, and Avila Therapeutics, Inc., a biotechnology company designing targeted covalent drugs, announced today an agreement for the development and commercialization of Avila's epidermal growth factor receptor (EGFR) mutant-selective inhibitor (EMSI) program, currently in pre-clinical development for the treatment of non-small cell lung cancer (NSCLC).
Nuvo Research Inc., a pharmaceutical company dedicated to building a portfolio of products primarily for the treatment of pain, today announced that it has entered into an agreement to acquire ZARS Pharma, Inc., a specialty pharmaceutical company based in Salt Lake City, Utah.
› Verified 1 days ago
| Entity Name | Sanford Health Of Northern Minnesota |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770849697 PECOS PAC ID: 5597725168 Enrollment ID: O20041025000442 |
News Archive
The Association for Molecular Pathology (AMP) is an international medical and professional association representing approximately 1,800 physicians, doctoral scientists, and medical laboratory scientists who perform laboratory testing based on knowledge derived from molecular biology, genetics, and genomics. AMP applauds US District Judge Robert Sweet's ruling in favor of the plaintiffs in the lawsuit, Association for Molecular Pathology, et al. v. U.S. Patent and Trademark Office, et al.
A French–Spanish research team has now developed a new type of carrier that can take on a particularly large "load" of medication and then release it in a controlled fashion: metal–organic frameworks with large cavities.
With a bipartisan budget deal behind it, Congress may be on the verge of solving the way it makes Medicare payments to doctors. Meanwhile, national spending on health care is growing at the slowest pace ever recorded, according to The New York Times.
Clovis Oncology, Inc., a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents, and Avila Therapeutics, Inc., a biotechnology company designing targeted covalent drugs, announced today an agreement for the development and commercialization of Avila's epidermal growth factor receptor (EGFR) mutant-selective inhibitor (EMSI) program, currently in pre-clinical development for the treatment of non-small cell lung cancer (NSCLC).
Nuvo Research Inc., a pharmaceutical company dedicated to building a portfolio of products primarily for the treatment of pain, today announced that it has entered into an agreement to acquire ZARS Pharma, Inc., a specialty pharmaceutical company based in Salt Lake City, Utah.
› Verified 1 days ago
| Entity Name | Hennepin Healthcare System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033138136 PECOS PAC ID: 4789684861 Enrollment ID: O20070207000467 |
News Archive
The Association for Molecular Pathology (AMP) is an international medical and professional association representing approximately 1,800 physicians, doctoral scientists, and medical laboratory scientists who perform laboratory testing based on knowledge derived from molecular biology, genetics, and genomics. AMP applauds US District Judge Robert Sweet's ruling in favor of the plaintiffs in the lawsuit, Association for Molecular Pathology, et al. v. U.S. Patent and Trademark Office, et al.
A French–Spanish research team has now developed a new type of carrier that can take on a particularly large "load" of medication and then release it in a controlled fashion: metal–organic frameworks with large cavities.
With a bipartisan budget deal behind it, Congress may be on the verge of solving the way it makes Medicare payments to doctors. Meanwhile, national spending on health care is growing at the slowest pace ever recorded, according to The New York Times.
Clovis Oncology, Inc., a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents, and Avila Therapeutics, Inc., a biotechnology company designing targeted covalent drugs, announced today an agreement for the development and commercialization of Avila's epidermal growth factor receptor (EGFR) mutant-selective inhibitor (EMSI) program, currently in pre-clinical development for the treatment of non-small cell lung cancer (NSCLC).
Nuvo Research Inc., a pharmaceutical company dedicated to building a portfolio of products primarily for the treatment of pain, today announced that it has entered into an agreement to acquire ZARS Pharma, Inc., a specialty pharmaceutical company based in Salt Lake City, Utah.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel George Hoody, MD Po Box 5074, Sioux Falls, SD 57117-5074 Ph: (605) 328-9419 | Dr Daniel George Hoody, MD 1300 Anne St Nw, Bemidji, MN 56601-5103 Ph: (218) 333-5000 |
News Archive
The Association for Molecular Pathology (AMP) is an international medical and professional association representing approximately 1,800 physicians, doctoral scientists, and medical laboratory scientists who perform laboratory testing based on knowledge derived from molecular biology, genetics, and genomics. AMP applauds US District Judge Robert Sweet's ruling in favor of the plaintiffs in the lawsuit, Association for Molecular Pathology, et al. v. U.S. Patent and Trademark Office, et al.
A French–Spanish research team has now developed a new type of carrier that can take on a particularly large "load" of medication and then release it in a controlled fashion: metal–organic frameworks with large cavities.
With a bipartisan budget deal behind it, Congress may be on the verge of solving the way it makes Medicare payments to doctors. Meanwhile, national spending on health care is growing at the slowest pace ever recorded, according to The New York Times.
Clovis Oncology, Inc., a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents, and Avila Therapeutics, Inc., a biotechnology company designing targeted covalent drugs, announced today an agreement for the development and commercialization of Avila's epidermal growth factor receptor (EGFR) mutant-selective inhibitor (EMSI) program, currently in pre-clinical development for the treatment of non-small cell lung cancer (NSCLC).
Nuvo Research Inc., a pharmaceutical company dedicated to building a portfolio of products primarily for the treatment of pain, today announced that it has entered into an agreement to acquire ZARS Pharma, Inc., a specialty pharmaceutical company based in Salt Lake City, Utah.
› Verified 1 days ago
Wai Lun Chan, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1233 34th St Nw, Bemidji, MN 56601 Phone: 218-333-5280 Fax: 218-333-5360 | |
Dr. Timothy Joseph Edmiston, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1300 Anne St Nw, Bemidji, MN 56601 Phone: 813-468-7412 |